Skip to main content
Top
Published in: Journal of Gastrointestinal Surgery 10/2015

01-10-2015 | Original Article

Trends in the Surgical Management of Crohn’s Disease

Authors: Cristina B. Geltzeiler, Kyle D. Hart, Kim C. Lu, Karen E. Deveney, Daniel O. Herzig, Vassiliki L. Tsikitis

Published in: Journal of Gastrointestinal Surgery | Issue 10/2015

Login to get access

Abstract

Introduction

Although medical management of Crohn’s disease has changed in recent years, it is unclear whether surgical management has altered. We examined rate changes of surgical interventions, stoma constructions, and subset of ileostomy and colostomy constructions.

Materials and Methods

We reviewed the Nationwide Inpatient Sample database from 1988 to 2011. We examined the number of Crohn’s-related operations and stoma constructions, including ileostomies and colostomies; a multivariable logistic regression model was developed.

Results

A total of 355,239 Crohn’s-related operations were analyzed. Operations increased from 13,955 in 1988 to 17,577 in 2011, p < 0.001. Stoma construction increased from 2493 to 4283, p < 0.001. The subset of ileostomies increased from 1201 to 3169, p < 0.001 while colostomies decreased from 1351 to 1201, p = 0.05. Operation percentages resulting in stoma construction increased from 18 to 24 %, p < 0.001. Weight loss (OR 2.25, 95 % CI 1.88, 2.69) and presence of perianal fistulizing disease (OR 2.91, 95 % CI 2.31, 3.67) were most predictive for requiring stoma construction.

Conclusions

Crohn’s-related surgical interventions and stoma constructions have increased. The largest predictors for stoma construction are weight loss and perianal fistulizing disease. As a result, nutrition should be optimized and the early involvement of a multidisciplinary team should be considered.
Appendix
Available only for authorised users
Literature
1.
go back to reference Kornbluth A. Infliximab approved for use in Crohn's disease: a report on the FDA GI Advisory Committee conference. Inflamm Bowel Dis 1998;4:328–9.PubMed Kornbluth A. Infliximab approved for use in Crohn's disease: a report on the FDA GI Advisory Committee conference. Inflamm Bowel Dis 1998;4:328–9.PubMed
2.
go back to reference Hanauer SB, Feagan BG, Lichtenstein GR, Mayer LF, Schreiber S, Colombel JF Rachmilewitz, D, Wolf DC, Olson A, Bao W, Rutgeerts P. Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial. Lancet 2002;359:1541–9CrossRefPubMed Hanauer SB, Feagan BG, Lichtenstein GR, Mayer LF, Schreiber S, Colombel JF Rachmilewitz, D, Wolf DC, Olson A, Bao W, Rutgeerts P. Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial. Lancet 2002;359:1541–9CrossRefPubMed
3.
go back to reference Lichtenstein GR, Yan S, Bala M, Hanauer S. Remission in patients with Crohn's disease is associated with improvement in employment and quality of life and a decrease in hospitalizations and surgeries. Am J Gastroenterol 2004;99: 91–6.CrossRefPubMed Lichtenstein GR, Yan S, Bala M, Hanauer S. Remission in patients with Crohn's disease is associated with improvement in employment and quality of life and a decrease in hospitalizations and surgeries. Am J Gastroenterol 2004;99: 91–6.CrossRefPubMed
4.
go back to reference Costa J, Magro F, Caldeira D, Alarcao J, Sousa R, Vaz-Carneiro A. Infliximab reduces hospitalizations and surgery interventions in patients with inflammatory bowel disease: a systematic review and meta-analysis. Inflamm Bowel Dis 2013;19:2098–110.CrossRefPubMed Costa J, Magro F, Caldeira D, Alarcao J, Sousa R, Vaz-Carneiro A. Infliximab reduces hospitalizations and surgery interventions in patients with inflammatory bowel disease: a systematic review and meta-analysis. Inflamm Bowel Dis 2013;19:2098–110.CrossRefPubMed
5.
go back to reference Bernell O, Lapidus A, Hellers G. Risk factors for surgery and recurrence in 907 patients with primary ileocaecal Crohn's disease. Br J Surg., 2000. 87(12): p. 1697–701.CrossRefPubMed Bernell O, Lapidus A, Hellers G. Risk factors for surgery and recurrence in 907 patients with primary ileocaecal Crohn's disease. Br J Surg., 2000. 87(12): p. 1697–701.CrossRefPubMed
6.
go back to reference Farmer RG, Whelan G, Fazio VW. Long-term follow-up of patients with Crohn's disease. Relationship between the clinical pattern and prognosis. Gastroenterology 1985;88:1818–25.PubMed Farmer RG, Whelan G, Fazio VW. Long-term follow-up of patients with Crohn's disease. Relationship between the clinical pattern and prognosis. Gastroenterology 1985;88:1818–25.PubMed
7.
go back to reference Fielding JF, Collins PG, Lane BE, Osborne HD. Surgery for Crohn's disease in Ireland. Dis Colon Rectum 1986;29: 230–3.CrossRefPubMed Fielding JF, Collins PG, Lane BE, Osborne HD. Surgery for Crohn's disease in Ireland. Dis Colon Rectum 1986;29: 230–3.CrossRefPubMed
8.
go back to reference Heimann TM, Greenstein AJ, Lewis B, Kaufman D, Heimann DM, Aufses Jr AH. Comparison of primary and reoperative surgery in patients with Crohns disease. Ann Surg 1998;227:492–5.PubMedCentralCrossRefPubMed Heimann TM, Greenstein AJ, Lewis B, Kaufman D, Heimann DM, Aufses Jr AH. Comparison of primary and reoperative surgery in patients with Crohns disease. Ann Surg 1998;227:492–5.PubMedCentralCrossRefPubMed
10.
go back to reference Bouguen G, Peyrin-Biroulet L. Surgery for adult Crohn's disease: what is the actual risk? Gut 2011;60:1178–81.CrossRefPubMed Bouguen G, Peyrin-Biroulet L. Surgery for adult Crohn's disease: what is the actual risk? Gut 2011;60:1178–81.CrossRefPubMed
11.
go back to reference Peyrin-Biroulet L, Oussalah A, Williet N, Pillot C, Bresler L, Bigard MA. Impact of azathioprine and tumour necrosis factor antagonists on the need for surgery in newly diagnosed Crohn's disease. Gut 2011;60:930–6.CrossRefPubMed Peyrin-Biroulet L, Oussalah A, Williet N, Pillot C, Bresler L, Bigard MA. Impact of azathioprine and tumour necrosis factor antagonists on the need for surgery in newly diagnosed Crohn's disease. Gut 2011;60:930–6.CrossRefPubMed
12.
go back to reference Samimi R, Flasar MH, Kavic S, Tracy K, Cross RK. Outcome of medical treatment of stricturing and penetrating Crohn's disease: a retrospective study. Inflamm Bowel Dis 2010;16:1187–94.CrossRefPubMed Samimi R, Flasar MH, Kavic S, Tracy K, Cross RK. Outcome of medical treatment of stricturing and penetrating Crohn's disease: a retrospective study. Inflamm Bowel Dis 2010;16:1187–94.CrossRefPubMed
13.
go back to reference Drossman DA, Patrick DL, Mitchell CM, Zagami EA, Appelbaum MI. Health-related quality of life in inflammatory bowel disease. Functional status and patient worries and concerns. Dig Dis Sci 1989;34:1379–86.CrossRefPubMed Drossman DA, Patrick DL, Mitchell CM, Zagami EA, Appelbaum MI. Health-related quality of life in inflammatory bowel disease. Functional status and patient worries and concerns. Dig Dis Sci 1989;34:1379–86.CrossRefPubMed
14.
go back to reference Cosnes J, Nion-Larmurier I, Beaugerie L, Afchain P, Tiert E, Gendre JP. Impact of the increasing use of immunosuppressants in Crohn's disease on the need for intestinal surgery. Gut 2005;54:237–41.PubMedCentralCrossRefPubMed Cosnes J, Nion-Larmurier I, Beaugerie L, Afchain P, Tiert E, Gendre JP. Impact of the increasing use of immunosuppressants in Crohn's disease on the need for intestinal surgery. Gut 2005;54:237–41.PubMedCentralCrossRefPubMed
15.
go back to reference Coscia M, Gentilini L, Laureti S, Gionchetti P, Rizzello F, Campieri M, Calabrese C, Poggioli G. Risk of permanent stoma in extensive Crohn's colitis: the impact of biological drugs. Colorectal Dis 2013;15:1115–22.PubMed Coscia M, Gentilini L, Laureti S, Gionchetti P, Rizzello F, Campieri M, Calabrese C, Poggioli G. Risk of permanent stoma in extensive Crohn's colitis: the impact of biological drugs. Colorectal Dis 2013;15:1115–22.PubMed
17.
go back to reference RC Team. R: A Language and Environment for Statistical Computing, 2014. RC Team. R: A Language and Environment for Statistical Computing, 2014.
18.
go back to reference TL. Analysis of Complex Survey Samples. J Statistical Software, 2004. 9: p. 1–19 TL. Analysis of Complex Survey Samples. J Statistical Software, 2004. 9: p. 1–19
19.
go back to reference Cosnes J, Gower-Rousseau C, Seksik P, Cortot A. Epidemiology and natural history of inflammatory bowel diseases. Gastroenterology 2011. 140: 1785–94.CrossRefPubMed Cosnes J, Gower-Rousseau C, Seksik P, Cortot A. Epidemiology and natural history of inflammatory bowel diseases. Gastroenterology 2011. 140: 1785–94.CrossRefPubMed
20.
go back to reference Jess T, Riis L, Vind I, Winther KV, Borg S, Binder V, Langholtz E, Thomsen OO, Munkholm P. Changes in clinical characteristics, course, and prognosis of inflammatory bowel disease during the last 5 decades: a population-based study from Copenhagen, Denmark. Inflamm Bowel Dis 2007;13:481–9.CrossRefPubMed Jess T, Riis L, Vind I, Winther KV, Borg S, Binder V, Langholtz E, Thomsen OO, Munkholm P. Changes in clinical characteristics, course, and prognosis of inflammatory bowel disease during the last 5 decades: a population-based study from Copenhagen, Denmark. Inflamm Bowel Dis 2007;13:481–9.CrossRefPubMed
21.
go back to reference Loftus CG, Loftus Jr EV, Harmsen WS, Zinsmeister AR, Tremaine WJ, Melton III LJ, Sandborn WJ. Update on the incidence and prevalence of Crohn's disease and ulcerative colitis in Olmsted County, Minnesota, 1940–2000. Inflamm Bowel Dis 2007;13:254–61.CrossRefPubMed Loftus CG, Loftus Jr EV, Harmsen WS, Zinsmeister AR, Tremaine WJ, Melton III LJ, Sandborn WJ. Update on the incidence and prevalence of Crohn's disease and ulcerative colitis in Olmsted County, Minnesota, 1940–2000. Inflamm Bowel Dis 2007;13:254–61.CrossRefPubMed
22.
go back to reference Molodecky NA, Soon IS, Rabi DM, Ghai WA, Ferris M, Chernoff G, Benchimol EI, Panaccione R, Ghosh S, Barkema HW, Kaplan GG. Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. Gastroenterology 2012;142:46–54.e42; quiz e30 CrossRefPubMed Molodecky NA, Soon IS, Rabi DM, Ghai WA, Ferris M, Chernoff G, Benchimol EI, Panaccione R, Ghosh S, Barkema HW, Kaplan GG. Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. Gastroenterology 2012;142:46–54.e42; quiz e30 CrossRefPubMed
23.
go back to reference Vind I, Riis L, Jess T, Knudsen E, Pedersen N, Elkjaer M, Bak Andersen I, Wewer V, Norregaard P, Moesgaard F, Bendtsen F, Munkholm P. Increasing incidences of inflammatory bowel disease and decreasing surgery rates in Copenhagen City and County, 2003–2005: a population-based study from the Danish Crohn colitis database. Am J Gastroenterol 2006;101:1274–82.CrossRefPubMed Vind I, Riis L, Jess T, Knudsen E, Pedersen N, Elkjaer M, Bak Andersen I, Wewer V, Norregaard P, Moesgaard F, Bendtsen F, Munkholm P. Increasing incidences of inflammatory bowel disease and decreasing surgery rates in Copenhagen City and County, 2003–2005: a population-based study from the Danish Crohn colitis database. Am J Gastroenterol 2006;101:1274–82.CrossRefPubMed
24.
go back to reference Loftus Jr EV. Clinical epidemiology of inflammatory bowel disease: Incidence, prevalence, and environmental influences. Gastroenterology 2004;126:1504–17.CrossRefPubMed Loftus Jr EV. Clinical epidemiology of inflammatory bowel disease: Incidence, prevalence, and environmental influences. Gastroenterology 2004;126:1504–17.CrossRefPubMed
25.
go back to reference Wolters FL, Russel MG, Stockbrugger RW. Systematic review: has disease outcome in Crohn's disease changed during the last four decades? Aliment Pharmacol Ther 2004;20:483–96.CrossRefPubMed Wolters FL, Russel MG, Stockbrugger RW. Systematic review: has disease outcome in Crohn's disease changed during the last four decades? Aliment Pharmacol Ther 2004;20:483–96.CrossRefPubMed
26.
go back to reference Geltzeiler CB, Lu KC, Diggs BS, Deveney KE, Keyashian K, Herzig DO, Tsikitis VL. Initial surgical management of ulcerative colitis in the biologic era. Dis Colon Rectum 2014;57:1358–63.CrossRefPubMed Geltzeiler CB, Lu KC, Diggs BS, Deveney KE, Keyashian K, Herzig DO, Tsikitis VL. Initial surgical management of ulcerative colitis in the biologic era. Dis Colon Rectum 2014;57:1358–63.CrossRefPubMed
27.
go back to reference El-Hussuna A, Krag A, Olaison G, Bendtsen F, Gluud LL. The effect of anti-tumor necrosis factor alpha agents on postoperative anastomotic complications in Crohn's disease: a systematic review. Dis Colon Rectum 2013;56:1423–33.CrossRefPubMed El-Hussuna A, Krag A, Olaison G, Bendtsen F, Gluud LL. The effect of anti-tumor necrosis factor alpha agents on postoperative anastomotic complications in Crohn's disease: a systematic review. Dis Colon Rectum 2013;56:1423–33.CrossRefPubMed
28.
go back to reference Yang ZP, Hong L, Wu Q, Wu KC, Fan DM. Preoperative infliximab use and postoperative complications in Crohn's disease: a systematic review and meta-analysis. Int J Surg, 2014;12:224–30.CrossRefPubMed Yang ZP, Hong L, Wu Q, Wu KC, Fan DM. Preoperative infliximab use and postoperative complications in Crohn's disease: a systematic review and meta-analysis. Int J Surg, 2014;12:224–30.CrossRefPubMed
31.
go back to reference Gu J, Valente MA, Rezmi FH, Stocchi L. Factors affecting the fate of faecal diversion in patients with perianal Crohn's disease. Colorectal Dis 2015;17:66–72.CrossRefPubMed Gu J, Valente MA, Rezmi FH, Stocchi L. Factors affecting the fate of faecal diversion in patients with perianal Crohn's disease. Colorectal Dis 2015;17:66–72.CrossRefPubMed
32.
go back to reference Knowles SR, Wilson J, Wilkinson A, Connell W, Saltzberg M, Castle D, Desmond P, Kamm MA. Psychological well-being and quality of life in Crohn's disease patients with an ostomy: a preliminary investigation. J Wound Ostomy Continence Nurs, 2013;40:623–9.CrossRefPubMed Knowles SR, Wilson J, Wilkinson A, Connell W, Saltzberg M, Castle D, Desmond P, Kamm MA. Psychological well-being and quality of life in Crohn's disease patients with an ostomy: a preliminary investigation. J Wound Ostomy Continence Nurs, 2013;40:623–9.CrossRefPubMed
33.
go back to reference Zerbib P, Koriche D, Truant S, Bouras AF, Vernier-Massouille G, Seguy D, Pruvot FR, Cortot A, Colombel JF. Pre-operative management is associated with low rate of post-operative morbidity in penetrating Crohn's disease. Aliment Pharmacol Ther 2010;32:459–65.CrossRefPubMed Zerbib P, Koriche D, Truant S, Bouras AF, Vernier-Massouille G, Seguy D, Pruvot FR, Cortot A, Colombel JF. Pre-operative management is associated with low rate of post-operative morbidity in penetrating Crohn's disease. Aliment Pharmacol Ther 2010;32:459–65.CrossRefPubMed
Metadata
Title
Trends in the Surgical Management of Crohn’s Disease
Authors
Cristina B. Geltzeiler
Kyle D. Hart
Kim C. Lu
Karen E. Deveney
Daniel O. Herzig
Vassiliki L. Tsikitis
Publication date
01-10-2015
Publisher
Springer US
Published in
Journal of Gastrointestinal Surgery / Issue 10/2015
Print ISSN: 1091-255X
Electronic ISSN: 1873-4626
DOI
https://doi.org/10.1007/s11605-015-2911-3

Other articles of this Issue 10/2015

Journal of Gastrointestinal Surgery 10/2015 Go to the issue